📐 SAT
📝 ACT
🎓 AP Exams

AP Biology: Unit 4, Cell Cycle & Regulation (Drill 15)

Drill 15 ·

0 / 5
Previous drill
Drill 14
Next drill
Drill 16
More AP Bio drills
Drill 1 5 questions → Drill 2 5 questions → Drill 3 5 questions → Drill 4 5 questions → Drill 5 5 questions → Drill 6 5 questions → Drill 7 5 questions → Drill 8 5 questions → Drill 9 5 questions → Drill 10 5 questions → Drill 11 5 questions → Drill 12 5 questions → Drill 13 5 questions → Drill 14 5 questions →
Drill 15 — current you are here
Drill 16 5 questions → Drill 17 5 questions → Drill 18 5 questions → Drill 19 5 questions → Drill 20 5 questions → Drill 21 5 questions → Drill 22 5 questions → Drill 23 5 questions → Drill 24 5 questions → Drill 25 5 questions → Drill 26 5 questions → Drill 27 5 questions → Drill 28 5 questions → Drill 29 5 questions → Drill 30 5 questions → Drill 31 5 questions → Drill 32 5 questions → Drill 33 5 questions → Drill 34 5 questions → Drill 35 5 questions → Drill 36 5 questions → Drill 37 5 questions →

About This Drill

AP Biology: Unit 4, Cell Cycle & Regulation (Drill 15) is a practice drill. It contains 5 original questions created by Brian Stewart, a Barron's test prep author with over 20 years of tutoring experience.

Analyze cell cycle phase distributions in normal and tumor cell lines, and evaluate how CDK inhibitors and checkpoint proteins regulate cell division.

Passage

Researchers studying cancer biology examine cell division in two human cell lines: a normal epithelial cell line (Line N) and a tumor-derived cell line (Line T). They measure the percentage of cells in each phase of the cell cycle at a given time point, and test the effect of a CDK inhibitor drug on cell proliferation.
Cell Cycle Phase Distribution:
G1: Line N 45%Line T 18%
S: Line N 20%Line T 47%
G2: Line N 15%Line T 28%
M: Line N 10%Line T 6%
G0: Line N 10%Line T 1%

A CDK (cyclin-dependent kinase) inhibitor is applied to both cell lines at the same concentration. After 48 hours, Line N shows a 12% reduction in cell number while Line T shows a 67% reduction.

Questions & Explanations

Question 1. Based on the table, which conclusion about Line T is most directly supported by the data?

  • A) Line T cells divide faster than Line N cells because a higher percentage are in M phase.
  • B) Line T cells are more likely to be actively replicating DNA at any given time than Line N cells. ✓
  • C) Line T cells are less likely to enter S phase and replicate their DNA than Line N cells as described in the passage.
  • D) Line T cells cannot enter G0 because tumor cells lack the machinery for quiescence.

Explanation: The table shows 47% of Line T cells are in S phase (DNA replication) compared to 20% of Line N cells. At any given snapshot, nearly half of Line T cells are actively replicating DNA, directly supporting the conclusion that Line T is more likely to be replicating at any given time. A is incorrect because a lower percentage of Line T cells are in M phase (6% vs. 10%). C is incorrect because the data show phase distribution at a single time point, not the duration of each phase or the total cycle length. D overstates the data -- Line T has 1% of cells in G0, meaning some cells can still enter quiescence.

Question 2. A researcher proposes that Line T cells are less responsive to internal checkpoint signals that would normally halt cell cycle progression. Which finding from the table is most consistent with this proposal?

  • A) Line T has fewer cells in M phase than Line N, indicating that its cells are pausing at internal checkpoints rather than progressing through division.
  • B) Line T has more cells in S and G2 phases combined, suggesting cells are progressing through the cycle without pausing.
  • C) Line T has only 1% of cells in G0, indicating that most cells are cycling rather than responding to quiescence signals.
  • D) Line T has only 18% of cells in G1 compared to 45% in Line N, consistent with cells bypassing the G1 checkpoint and committing to S phase without appropriate signals. ✓

Explanation: The G1 checkpoint (restriction point) is the primary decision point at which normal cells integrate growth signals and DNA integrity checks before committing to S phase. Line T's low G1 occupancy (18% vs. 45%) is consistent with cells bypassing this checkpoint. D is superior to C because the G1 checkpoint is specifically an internal cell cycle control mechanism, whereas G0 exit reflects external quiescence signals -- making D more directly relevant to the proposal. B describes the outcome of checkpoint bypass but does not identify a specific checkpoint mechanism. A does not suggest checkpoint bypass.

Question 3. CDK inhibitors reduce cell proliferation by blocking cyclin-dependent kinases. Which mechanism best explains why Line T shows a greater reduction in cell number than Line N after CDK inhibitor treatment?

  • A) Line T cells are more sensitive to all drugs because tumor cells have thinner membranes that allow greater drug uptake.
  • B) Line T cells have a higher proportion of cells actively cycling, so more cells are dependent on CDK activity at the time of treatment. ✓
  • C) Line T cells lack G0 cells entirely, so every single cell is simultaneously affected by CDK inhibition at the moment of treatment in the treatment scenario described.
  • D) CDK inhibitors preferentially target tumor cells because tumor CDKs have a different molecular structure than normal CDKs.

Explanation: CDK activity is required for cell cycle progression, particularly at the G1/S and G2/M transitions. Line T has far more actively cycling cells (47% in S, 28% in G2, only 1% in G0). Cells in G0 are less dependent on CDK activity and therefore less affected by CDK inhibition. The greater proportion of actively cycling cells in Line T explains the greater reduction. A is biologically unsupported. C overstates the data -- 1% of Line T cells are in G0, not zero. D is incorrect -- no molecular selectivity for tumor CDKs is indicated.

Question 4. A student argues that the CDK inhibitor would be a more effective cancer treatment if it could be modified to exclusively target cells in S phase. Which reasoning best evaluates this argument?

  • A) The argument is well-supported because S-phase cells are undergoing DNA replication, which makes them uniquely and exclusively vulnerable to CDK inhibition.
  • B) The argument is flawed because CDK inhibitors work at the G1/S checkpoint, not within S phase itself, so targeting S phase cells would have no effect.
  • C) The argument has merit because Line T has 47% of cells in S phase, meaning an S-phase-specific drug would affect nearly half the tumor cells at any given time -- but cells in other active phases would be spared, limiting effectiveness. ✓
  • D) The argument is flawed because all cycling cells are equally dependent on CDK activity regardless of phase, so phase-specific targeting offers no advantage.

Explanation: The argument has partial merit -- targeting S phase cells would affect a large fraction of Line T cells (47%) given the phase distribution in the table. However, cells in G2 (28%) and other active phases would not be targeted, potentially allowing them to continue cycling. C correctly identifies both the strength of the argument and its limitation. A overstates the case by calling S phase cells "uniquely vulnerable" without mechanistic support. B is incorrect because CDKs are active during S phase as well as at checkpoints. D is incorrect because CDK activity varies by phase -- different cyclin-CDK complexes are active at different points in the cycle.

Question 5. In normal cells, the retinoblastoma protein (Rb) acts as a tumor suppressor by inhibiting progression from G1 into S phase. Which molecular event would most likely result in a cell cycle profile similar to Line T?

  • A) Overexpression of Rb, causing cells to remain in G1 indefinitely.
  • B) Loss-of-function mutation in Rb, allowing cells to enter S phase without appropriate growth signals. ✓
  • C) Overexpression of a CDK inhibitor protein, preventing cyclin-CDK complex formation at the G1/S boundary.
  • D) Deletion of S phase cyclins, preventing DNA replication initiation.

Explanation: Rb normally acts as a brake at the G1/S transition -- when hypophosphorylated, it binds and inhibits E2F transcription factors needed for S phase entry. A loss-of-function mutation in Rb removes this brake, allowing cells to enter S phase without appropriate signals, producing fewer cells in G1 and more in S phase -- consistent with Line T. A would produce the opposite: cells accumulating in G1. C would also cause G1 accumulation by preventing the cyclin-CDK phosphorylation of Rb needed for S phase entry. D would block cells at the G1/S boundary rather than producing high S phase occupancy.